MUMBAI, India, June 27 -- Intellectual Property India has published a patent application (202517054658 A) filed by Beigene Switzerland Gmbh, Basel, Switzerland, on June 6, for 'anti-cd137 antibodies and methods of use.'
Inventor(s) include Qu, Liang; Xue, Liu; Ji, Ruyue; Yuan, Xi; Li, Zhuo; Li, Jie; and Sun, Jian.
The application for the patent was published on June 27, under issue no. 26/2025.
According to the abstract released by the Intellectual Property India: "The present disclosure provides for the antibodies or antigen-binding fragment thereof that specifically binds human CD137, multispecific antibodies and antigen-binding fragments thereof that specifically bind to human GPC3 and CD137, a pharmaceutical composition comprising said antibody, and use of the antibody, multispecific antibody or the composition for treating a disease, such as cancer."
The patent application was internationally filed on Nov. 20, 2023, under International application No.PCT/CN2023/132564.
Disclaimer: Curated by HT Syndication.
